Kidney Cancer Doctors Abroad — Page 3

Dr Saban Sec serves as a national representative for the Turkish Medical Oncology Association, where he leads efforts in managing complex urogenital cancers.

• Specialises in urogenital cancers, including malignant tumours of the kidney and bladder
• Uses targeted systemic therapies to manage both localized and metastatic kidney cancer cases
• Trained at Istanbul University Prof Dr Cemil Tascioglu City Hospital, a major centre for oncology research
• Contributes to international oncology research focusing on prognostic factors and patient survival rates

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Associate Professor Yusuf Acikgoz brings high-level expertise from The Ohio State University to his role leading medical oncology at Lokman Hekim University.

• Specialises in systemic therapies for kidney cancer including immunotherapy and targeted drug regimes
• Served as an investigator on major Phase III global clinical trials for new cancer treatments
• Completed specialised immuno-oncology training with the Central European Cooperative Oncology Group in Vienna
• Active member of the American Society of Clinical Oncology since 2022
• Recognised for clinical research involving human subjects protection and laboratory animal research standards

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Associate Professor Nail Paksoy is a European-certified medical oncologist specialising in advanced kidney cancer treatments and immunotherapy at Medipol Bahçelievler University Hospital.

• ESMO Board Certified in Medical Oncology – recognised for meeting high European standards in cancer care
• Expert in metastatic renal cell carcinoma (RCC) – handles complex cases with spread to the brain or other organs
• Focuses on immunotherapy protocols including Atezolizumab for improved outcomes in urological cancers
• Sub-investigator for international clinical trials with major pharmaceutical companies like Roche and Pfizer
• Extensively published in uro-oncology with specific research on drug resistance in kidney cancer

Professor Alemdar is a medical oncology specialist at the Medical Park Antalya Hospital Complex with deep roots in academic medicine.

• Trained at Akdeniz University across internal medicine and medical oncology subspecialties
• Managed complex oncology cases at Antalya Training and Research Hospital
• Focuses on systemic treatments for kidney cancer including immunotherapy and targeted drug protocols
• Experienced in multi-disciplinary care settings at major Turkish university hospitals